Quantcast

Latest HBV Stories

2011-10-24 09:21:24

Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to a cohort study published online October 21 in the Journal of the National Cancer Institute. While a causal link between hepatitis B and C and hepatocellular cancer has been known for a few decades, tobacco smoking, obesity, and alcohol consumption are common risk...

2011-07-25 08:00:00

JOHANNESBURG, July 25, 2011 /PRNewswire/ -- The South African National Blood Service (SANBS) presented new data which demonstrated that its use of Novartis nucleic acid testing (NAT) products to screen donated blood for HIV and Hepatitis has resulted in a significant increase in the safety of the South African blood supply. The data underscores SANBS' recent celebration of five years of successful effort to prevent the spread of HIV and Hepatitis from transfusion of infected blood. In...

2011-05-10 15:43:05

Health outcomes explored at DDW 2011 According to new research at Columbia Presbyterian Medical Center, high rates of chronic hepatitis B infection (HBV) are found in pregnant minority and immigrant women in the New York City area, and most of them do not receive education, appropriate follow-up testing or referral, which is considered the standard of care for all persons newly identified as HBV carriers. Results showed that while all but one infant was protected from infection in this study,...

2011-04-03 21:56:55

First new hepatitis B and D treatment for many years Promising new viral hepatitis data presented today at the International Liver CongressTM show that entry inhibitors --a new mechanism of action for drugs to treat viral hepatitis -- could provide the first new hepatitis B and hepatitis D treatments for many years. Most current approved therapies directly target viral replication (e.g. nucleotide/side analogues), and can lead to the development of viral resistance or viral rebound after the...

2010-11-01 08:35:00

BOSTON, Nov. 1, 2010 /PRNewswire/ -- Researchers studied the treatment of pregnant women with hepatitis B virus (HBV) with Telbivudine in their second to third trimesters. The study concluded that both the mothers benefited from treatment and no transmission of HBV to newborns was detected at 28 weeks postbirth. The study presenter and co-investigator Calvin Pan, MD, anticipates a "very powerful impact in the field, as hepatitis B is difficult to eradicate and currently there is no...

2010-10-20 14:37:00

Panel calls for a conservative approach until more clinical data and therapeutic options are available DOYLESTOWN, Pa., Oct. 20 /PRNewswire-USNewswire/ -- In a report published on October 1, 2010 in the journal Hepatology (online), an expert panel of nationally recognized pediatric liver specialists convened by the Hepatitis B Foundation established the first national recommendations for the treatment of children with chronic hepatitis B virus (HBV) infections. Following their first...

2010-10-12 14:58:00

GERMANTOWN, Maryland and DES PLAINES, Illinois, October 12, 2010 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Abbott (ABT: NYSE) today announced that they have entered into an agreement that significantly strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada. Financial terms were not disclosed. Under the terms of the agreements, QIAGEN will receive kits for a PCR-based molecular...

2010-09-27 09:00:00

WASHINGTON, Sept. 27 /PRNewswire/ -- The American Association for the Study of Liver Diseases (AASLD) and the Trust for America's Health (TFAH) issued a new report today calling for action to be taken to transform how the country deals with viral hepatitis - to help identify millions of Americans who know they are living with chronic forms of hepatitis B and C and to assure access to treatment for all who need it, to prevent even more Americans from becoming infected. "This report is a...

2010-09-22 13:30:00

PLEASANTON, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV...

2010-09-14 10:00:00

WASHINGTON, DOYLESTOWN, Penn., and SAN FRANCISCO, Sept. 14 /PRNewswire/ -- The U.S. Department of Health and Human Services' Office of Minority Health, the Hepatitis B Foundation and the Association of Asian Pacific Community Health Organizations (AAPCHO) today launched a new campaign to raise awareness of the epidemic of chronic hepatitis B among Americans of Asian and Pacific Islander heritage. Chronic hepatitis B is a life-threatening liver disease caused by the hepatitis B virus...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related